Top Markets
Coin of the day
Pathfinder Cell Therapy, Inc. Pathfinder Cell Therapy, Inc.

Pathfinder Cell Therapy, Inc.

PFND
Rank in Stocks #40886
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in... Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Share Price
$0.0001
Last synced: 2026-08-12
Market Cap
$66.72K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Pathfinder Cell Therapy, Inc. (PFND)

Category

Operating Margin for Pathfinder Cell Therapy, Inc. (PFND)
Operating Margin as of 2026 TTM: 0.00%
According to Pathfinder Cell Therapy, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Pathfinder Cell Therapy, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.